A Matched-Pair Analysis of Conventional Surgical Methods versus Enucleation for Pancreatic Neuroendocrine Tumors Abstract #2171

Introduction: Pancreatoduodenectomy and distal pancreatectomy are still main therapy for pancreatic neuroendocrine tumours (pNETs).Recently enucleation has also been increasingly used to treat pNETs.
Aim(s): The aim of this paper was to compare the clinical effects of conventional surgery and enucleation for pNETs.
Materials and methods: Clinical data of 106 patients undergoing conventional surgery or enucleation were collected from Dec. 1999 to Jun. 2017.Patients were divided into 53 groups according to related clinical factors such as pathologic grade, tumour location and function. All cases were originated single and less than 2-cm in size. Prognosis, postoperative pancreatic fistula (POPF) rate,long-term complications,operation time and blood loss were compared between the groups.
Conference: 15th Annual ENETS conference 2018 (2018)
Category: Surgical treatment and Ablative Therapies
Presenting Author: Weilin Mao

To read results and conclusion, please login ...

Further abstracts you may be interested in

#1597 The Diagnostic and Prognostic Value of Plasma CgA in Nonfunctional Pancreatic Neuroendocrine Neoplasms
Introduction: Controversies still remain on the diagnostic and prognostic value of CgA.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Biomarkers
Presenting Author: Yang Lv
Authors: Lv Y, Han X, Mao W, Zhou J, ...
#1599 The Value of Plasma CgA Combined with NSE Performed As the Real-Time Monitor of Clinical Characteristics in Gastroenteropancreatic Neuroendocrine Neoplasms after the Resection of Primary Lesions
Introduction: Controversies still remain on the clinical value of CgA and NSE.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Biomarkers
Presenting Author: Yang Lv
Authors: Lv Y, Han X, Mao W, Zhou J, ...
Keywords: cga, nse, nf-gep-nens
#1693 A Better Ki-67 Index Cutoff to Redefine Low Grade NET and High Grade NEC in Grade 3 Gastroenteropancreatic Neuroendocrine Neoplasms
Introduction: Heterogeneity of Grade 3 (G3) gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) was reported and well-differentiated G3 NET (neuroendocrine tumor) was classified by previous studies.
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Pathology, grading, staging
Presenting Author: Jie Chen
Authors: Shi H, Chen L, Zhang Q, Han C, ...
#1897 Prognosis of Sporadic Resected Small (≤ 2 cm) Nonfunctional Pancreatic Neuroendocrine Neoplasms - A Multi-Institutional Study
Introduction: Malignant potential of sporadic nonmetastatic nonfunctional pancreatic neuroendocrine tumors (sNF-PNET) is difficult to preoperatively predict
Conference: 14th Annual ENETS conference 2017 (2017)
Category: Surgical treatment
Presenting Author: Pr Sebastien Gaujoux
Keywords: pancreatic NETs
#2682 PAK4-NAMPT Dual Inhibition as a Novel Strategy for Therapy Resistant Pancreatic Neuroendocrine Tumors
Introduction: Pancreatic neuroendocrine tumors (PNET) remain an unmet clinical need. In this study, we show that targeting both nicotinamide phosphoribosyltransferase (NAMPT) and p21-activated kinase 4 (PAK4) could become a synthetic lethal strategy for PNET.
Conference: 17th Annual ENETS Conference 2020 (2020)
Category: Basic Science - Signaling pathways, receptors, biomarkers
Presenting Author: Ph.D. Candidate Gabriel Mpilla
Authors: Mpilla G, Aboukameel A, Muqbil I, Kim S, ...